TY - JOUR
T1 - Dampened antiviral immunity to intravaginal exposure to RNA viral pathogens allows enhanced viral replication
AU - Khan, Shahzada
AU - Woodruff, Erik M.
AU - Trapecar, Martin
AU - Fontaine, Krystal A.
AU - Ezaki, Ashley
AU - Borbet, Timothy C.
AU - Ott, Melanie
AU - Sanjabi, Shomyseh
N1 - Funding Information:
We thank M. Matloubian for LCMVArm stock and propagation protocols, J. Luong for help with maintaining the mouse colonies, and F. Wu for technical assistance. We are grateful to J. Cyster (University of California, San Francisco [UCSF]), M. Matloubian (UCSF), W. Greene (Gladstone Institute of Virology and Immunology/UCSF), and M. R. Jakobsen (Aarhus University) for critical reading of the manuscript and to G. Howard and C. Herron (Gladstone) for editorial assistance. This publication was made possible with help from the UCSF-Gladstone Institutes CFAR, an NIH-funded program (P30 AI027763) supporting Gladstone's flow core. The Gladstone Institutes received support for its animal care facility from a National Center for Research Resources grant (RR18928). This work was supported by grants from the National Institutes of Health (NIH; DP2 AI112244), a University of California Hellman Award, a Center for AIDS Research (CFAR) Pilot Award (P30 AI027763 and CNI HR P30 AI027767 to S. Sanjabi), a California Institute for Regenerative Medicine/Gladstone Institutes Fellowship (TG2-01160), a CFAR Mentored Scientist Award (P30 AI027763 to S. Khan), and a grant from the NIH (R01 AI097552 to M. Ott). The authors declare no competing financial interests. Author contributions: conceptualization, S. Sanjabi and S. Khan; methodology, S. Khan, A. Ezaki, and S. Sanjabi; formal analysis, S. Khan; investigation, S. Khan., E.M. Woodruff, M. Trapecar, and T.C. Borbet; resources, M. Ott and K.A. Fontaine; writing (original draft), S. Sanjabi and S. Khan; writing (review and editing), S. Sanjabi, S. Khan, M. Trapecar, M. Ott, and K.A. Fontaine; visualization, S. Khan and S. Sanjabi; supervision, S. Sanjabi and S. Khan; and funding acquisition, S. Sanjabi and M. Ott.
Publisher Copyright:
© 2016 Khan et al.
PY - 2016/12/12
Y1 - 2016/12/12
N2 - Understanding the host immune response to vaginal exposure to RNA viruses is required to combat sexual transmission of this class of pathogens. In this study, using lymphocytic choriomeningitis virus (LCMV) and Zika virus (ZIKV) in wild-type mice, we show that these viruses replicate in the vaginal mucosa with minimal induction of antiviral interferon and inflammatory response, causing dampened innate-mediated control of viral replication and a failure to mature local antigen-presenting cells (APCs). Enhancement of innate-mediated inflammation in the vaginal mucosa rescues this phenotype and completely inhibits ZIKV replication. To gain a better understanding of how this dampened innate immune activation in the lower female reproductive tract may also affect adaptive immunity, we modeled CD8 T cell responses using vaginal LCMV infection. We show that the lack of APC maturation in the vaginal mucosa leads to a delay in CD8 T cell activation in the draining lymph node and hinders the timely appearance of effector CD8 T cells in vaginal mucosa, thus further delaying viral control in this tissue. Our study demonstrates that vaginal tissue is exceptionally vulnerable to infection by RNA viruses and provides a conceptual framework for the male to female sexual transmission observed during ZIKV infection.
AB - Understanding the host immune response to vaginal exposure to RNA viruses is required to combat sexual transmission of this class of pathogens. In this study, using lymphocytic choriomeningitis virus (LCMV) and Zika virus (ZIKV) in wild-type mice, we show that these viruses replicate in the vaginal mucosa with minimal induction of antiviral interferon and inflammatory response, causing dampened innate-mediated control of viral replication and a failure to mature local antigen-presenting cells (APCs). Enhancement of innate-mediated inflammation in the vaginal mucosa rescues this phenotype and completely inhibits ZIKV replication. To gain a better understanding of how this dampened innate immune activation in the lower female reproductive tract may also affect adaptive immunity, we modeled CD8 T cell responses using vaginal LCMV infection. We show that the lack of APC maturation in the vaginal mucosa leads to a delay in CD8 T cell activation in the draining lymph node and hinders the timely appearance of effector CD8 T cells in vaginal mucosa, thus further delaying viral control in this tissue. Our study demonstrates that vaginal tissue is exceptionally vulnerable to infection by RNA viruses and provides a conceptual framework for the male to female sexual transmission observed during ZIKV infection.
UR - http://www.scopus.com/inward/record.url?scp=85008467258&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85008467258&partnerID=8YFLogxK
U2 - 10.1084/jem.20161289
DO - 10.1084/jem.20161289
M3 - Article
C2 - 27852793
AN - SCOPUS:85008467258
SN - 0022-1007
VL - 213
SP - 2913
EP - 2929
JO - Journal of Experimental Medicine
JF - Journal of Experimental Medicine
IS - 13
ER -